bioRxivMicrobiology
Altered gut microbial functional pathways in people with Irritable Bowel Syndrome enable precision health insights
E. Patridge, A. Gorakshakar, M. M. Molusky, O. Ogundijo, C. Julian, L. Hu, G. Antoine, M. Vuyisich, R. Wohlman, G. Banavar
Abstract
Functional gastrointestinal disorders present diagnostic and therapeutic challenges, and there is a strong need for molecular markers that enable early health insights and intervention. Herein, we present an approach to assess the gut microbiome with stool-based gut metatranscriptome data from a large adult human population (n = 80,570), using irritable bowel syndrome as an example that features both an abnormal gut microbiome and a spectrum of distinct conditions. We develop a suite of eight gut microbial functional pathway scores, each of which represents the activity of a set of interacting microbial functional features (based on KEGG orthology) relevant to known gut biochemical activities. We use a normative approach within a subpopulation (n = 9,350) to define "Good" and "Not Optimal" activities for these transcriptome-based gut pathway scores. We hypothesize that Not Optimal scores are associated with irritable bowel syndrome (IBS) and its subtypes (i.e., IBS-Constipation, IBS-Diarrhea, IBS-Mixed Type). We show that Not Optimal functional pathway scores are associated with higher odds of IBS or its subtypes within an independent cohort (n = 71,220) using both the Rome IV Diagnostic Questionnaire as well as self-reported phenotypes. Rather than waiting to diagnose IBS after symptoms appear, these functional pathway scores can help to provide early health insights into molecular pathways that may contribute to IBS. These molecular endpoints could also assist with measuring the efficacy of practical interventions, developing related algorithms, providing personalized nutritional recommendations, diagnostic support, and treatments for gastrointestinal disorders like IBS. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=68 SRC="FIGDIR/small/580548v4_ufig1.gif" ALT="Figure 1"> View larger version (19K): org.highwire.dtl.DTLVardef@d84aaeorg.highwire.dtl.DTLVardef@f2276org.highwire.dtl.DTLVardef@19fab7aorg.highwire.dtl.DTLVardef@1b2f738_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: metagenomics
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated gene-catalog and genome-resolved metagenomics reveal taxonomic and metabolic differences in the gut microbiome in irritable bowel syndrome
Mina Ansari, Mehregan Ebrahimi, … Kamran Bagheri Lankarani·bioRxiv·Sep 7, 2026
- Alterations in gut microbiome composition and function in irritable bowel syndrome and increased probiotic abundance with daily supplementation
J. Phan, D. Nair, … P. Cotter·mSystemsPeer-reviewed·Dec 21, 2021
- Gut microbiome, diet and symptom interactions in irritable bowel syndrome
J. Tap, S. Störsrud, … M. Simren·bioRxiv·Feb 25, 2020
- Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome
A. Pearl, H. Bootz, … N. Yissachar·bioRxiv·Aug 15, 2021
- Systematic Mining of gut microbiota biomarkers for IBD
Yuchen Zhang, Wenkai Lai, … Fenglong Yang·bioRxiv·Oct 10, 2024
- Integrated 16S rRNA Bioinformatics Analysis of Gut Microbiota, Predicted Pathways, and Candidate Biomarkers in Inflammatory Bowel Disease
Aman Zehra, Elamathi Natarajan·bioRxiv·Oct 19, 2026